HGH 191AA (Somatropin）H12 12iu*10vials

HGH 191AA (Growth Hormone) H12 12iu*10 bottles is an ultra-high activity, fully recombinant human growth hormone, belonging to the highest research specification. It is the top-tier enhanced product in the H-series portfolio, upgraded from the classic H8 and flagship product H10 formulas. Composed of 191 complete amino acids, it has 100% structural homology with natural human growth hormone, retaining complete biological activity, optimal growth hormone receptor affinity, and stable downstream signal transduction capabilities. Utilizing advanced high-purity recombinant expression and precision vacuum freeze-drying technology, H12 12iu exhibits higher specific activity and maximum pathway activation amplitude, demonstrating stronger anabolic and metabolic remodeling effects than the traditional 8iu and 10iu specifications. As an ultra-high standard, high-dose exogenous growth hormone direct supplement, it completely eliminates dependence on endogenous pituitary function, achieving ultra-high amplitude, linear dose, and highly controllable upregulation of the growth hormone/insulin-like growth factor-1 axis. Specifically designed for research on super-strong anabolic metabolism, deep systemic metabolic remodeling, high-load tissue damage repair, extreme anti-aging endocrine intervention, and high-standard peptide synergistic effects validation, this product is a top-tier, highly effective core reference substance for in-depth pharmacological mechanism research of high-threshold growth hormone and gradient-based preclinical efficacy studies.

Product Functions and Research Value

In cutting-edge systemic laboratory studies, HGH 191AA H12 fully activates the downstream JAK2/STAT5 signaling pathway of GH/IGF-1, comprehensively enhancing somatic cell proliferation, high-density lean muscle fiber synthesis, systemic visceral and subcutaneous fat decomposition and metabolism, and high-level basal metabolic regulation. Compared to the balanced efficacy of H8 and the standard high-efficiency H10, 12iu of H12 achieves comprehensive enhancement in core physiological phenotypes, exhibiting superior advantages in super-strong lean muscle hypertrophy and high-load damage repair, thorough visceral fat decomposition and deep metabolic remodeling, maximizing basal metabolic rate, significantly inhibiting cellular senescence, and high-standard, high-intensity somatic cell growth regulation. Unlike endogenous pulsatile growth hormone-releasing hormone (GHRH) peptides that depend on pituitary responses, exogenous 191AA H12 provides precise, high-dose linear growth hormone supplementation, completely avoiding individual differences in endogenous responses and experimental signal attenuation. This ensures ultra-stable and significant phenotypic output under long-term, high-intensity intervention. The 12iu ultra-high specification balances extremely high potency and research safety, making it perfectly suited for ultra-high dose gradient threshold screening, long-term extreme metabolic intervention modeling, exploration of high-intensity body composition optimization mechanisms, and validation of complex peptide stacking. It provides authoritative saturated data with maximum amplitude, ultra-high discrimination, and high reproducibility for in-depth research on high-threshold growth hormone pharmacology, extreme metabolic regulation, and advanced anti-aging physiology.

Core Product Advantages

1. 191AA All-Natural Homologous Ultra-High Activity Structure: The complete full-length human growth hormone amino acid sequence, without fragment truncation or structural mutations. Its molecular conformation is completely identical to natural human growth hormone, exhibiting superior receptor binding activity and physiological simulation realism, far superior to modified peptides and fragment peptide products. 2. 12iu Ultra-High Potency Upper Limit Specification: The single-vial dose exceeds the mainstream 8iu/10iu specifications, achieving the performance upper limit of the H-series in terms of growth hormone axis activation and systemic anabolism intensity. It completely solves the problem of insufficient intervention effect in traditional specifications, fully meeting the research needs of ultra-high thresholds. 3. Precise Linear High-Dose Exogenous Supplementation: Independently activates downstream metabolic and anabolism pathways, without relying on endogenous secretion from the hypothalamus-pituitary axis. The dose-response relationship exhibits excellent linearity and controllability, with significant extreme experimental phenotypes and negligible systematic errors, supporting high-precision pharmacological mechanism research. 4. Pharmaceutical-Grade Ultra-High Purity Quality Control: Employing upgraded multi-stage purification and fully locked vacuum freeze-drying processes, the protein activity remains intact, and its specific activity is stable. Free from foreign proteins and invalid fragments, ensuring ultra-pure experimental variables and accurate, authoritative, high-end research conclusions. 5. Advanced Standard Aseptic Integrated Packaging: 10 vials/box in aseptic integrated packaging; each batch undergoes rigorous HPLC high-purity testing.